Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives

Lipid-based drugs are emerging as an interesting class of novel anticancer drugs with the potential to target specific cancer cell metabolic pathways linked to their proliferation and invasiveness. In particular, ω-3 polyunsaturated fatty acids (PUFA) derivatives such as epoxides and their bioisoste...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrastazu Pereira, Gabriela, Rawling, Tristan, Pozzoli, Michele, Pazderka, Curtis, Chen, Yongjuan, Dunstan, Colin R., Murray, Michael, Sonvico, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215190/
https://www.ncbi.nlm.nih.gov/pubmed/30322115
http://dx.doi.org/10.3390/nano8100825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215190/
https://www.ncbi.nlm.nih.gov/pubmed/30322115
http://dx.doi.org/10.3390/nano8100825

Ejemplares similares